Abstract
Recently published urologic research results have focused on the management of prostate cancer, including the cardiovascular risks associated with androgen suppression therapy and the use of denosumab (Prolia, Xgeva—Amgen) to delay the development of bone metastasis; the efficacy and safety of dietary supplements, including the association between daily vitamin E use and prostate cancer; and the use of saw palmetto to manage benign prostatic hyperplasia (BPH) symptoms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
